Next Generation Cancer Diagnostic Devices Market - 2025-2033

February 2026 | 67 pages | ID: N64BC0CEA0BCEN
DataM Intelligence

Abstracts

Next Generation Cancer Diagnostic Devices Marketis is growing with a CAGR of 15.20% during the forecast period 2026-2035.

The Next Generation Cancer Diagnostic Devices Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Next Generation Cancer Diagnostic Devices Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Technology

• Next-generation Sequencing*
• qPCR & Multiplexing
• Lab-on-a-chip (LOAC)
• Protein Microarrays
• DNA Microarrays

By Cancer Type

• Lung Cancer*
• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
• Others

By Application

• Biomarker Development*
• CTC Analysis
• Proteomic Analysis
• Epigenetic Analysis
• Genetic Analysis

By End User

• Hospitals*
• Cancer Research Institutes
• Diagnostic Centres

Regional Analysis for Next Generation Cancer Diagnostic Devices Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Next Generation Cancer Diagnostic Devices Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Technology
3.2. Snippet by Cancer Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
  4.1.2. Increasing Demand for Next-Generation Cancer Diagnostic Devices
  4.1.3. Restraints
  4.1.4. High Costs of Advanced Diagnostics Technologies
  4.1.5. Opportunity
  4.1.6. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. BY TECHNOLOGY

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  6.1.2. Market Attractiveness Index, By Technology
6.2. Next-generation Sequencing*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. qPCR & Multiplexing
6.4. Lab-on-a-chip (LOAC)
6.5. Protein Microarrays
6.6. DNA Microarrays

7. BY CANCER TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  7.1.2. Market Attractiveness Index, By Cancer Type
7.2. Lung Cancer*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Breast Cancer
7.4. Colorectal Cancer
7.5. Cervical Cancer
7.6. Others

8. BY APPLICATION

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  8.1.2. Market Attractiveness Index, By Application
8.2. Biomarker Development*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. CTC Analysis
8.4. Proteomic Analysis
8.5. Epigenetic Analysis
8.6. Genetic Analysis

9. BY END USER

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Cancer Research Institutes
9.4. Diagnostic Centres

10. BY REGION

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  10.1.2. Market Attractiveness Index, By Region
10.2. North America
  10.2.1. Introduction
  10.2.2. Key Region-Specific Dynamics
  10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  10.2.8. The U.S.
  10.2.9. Canada
  10.2.10. Mexico
10.3. Europe
  10.3.1. Introduction
  10.3.2. Key Region-Specific Dynamics
  10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Product Type
  10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  10.3.9. Germany
  10.3.10. UK
  10.3.11. France
  10.3.12. Italy
  10.3.13. Spain
    10.3.13.1. Rest of Europe
10.4. South America
  10.4.1. Introduction
  10.4.2. Key Region-Specific Dynamics
  10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  10.4.8. Brazil
  10.4.9. Argentina
  10.4.10. Rest of South America
10.5. Asia-Pacific
  10.5.1. Introduction
  10.5.2. Key Region-Specific Dynamics
  10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  10.5.8. China
  10.5.9. India
  10.5.10. Japan
  10.5.11. South Korea
  10.5.12. Rest of Asia-Pacific
10.6. Middle East and Africa
  10.6.1. Introduction
  10.6.2. Key Region-Specific Dynamics
  10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
  10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. COMPETITIVE LANDSCAPE

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. COMPANY PROFILES

12.1. GE HealthCare*
  12.1.1. Company Overview
  12.1.2. Product Portfolio and Description
  12.1.3. Financial Overview
  12.1.4. Key Developments
12.2. Illumina, Inc.
12.3. Novartis AG
12.4. F. Hoffmann-La Roche Ltd
12.5. Koninklijke Philips N.V
12.6. QIAGEN
12.7. Agilent Technologies, Inc.
12.8. Abbott
12.9. Thermo Fisher Scientific Inc.
12.10. BD (LIST NOT EXHAUSTIVE)

13. APPENDIX

13.1. About Us and Services
13.2. Contact Us